The Enterprise Value as of September 2024 (TTM) for X4 Pharmaceuticals, Inc. (XFOR) is 40.79M

According to X4 Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 40.79M. This represents a change of -72.62% compared to the average of 148.96M of the last 4 quarters.

X4 Pharmaceuticals, Inc. (XFOR) Historical Enterprise Value (quarterly & annually)

How has XFOR Enterprise Value performed in the past?

The mean historical Enterprise Value of X4 Pharmaceuticals, Inc. over the last ten years is 36.42M. The current 40.79M Enterprise Value has changed 11.10% with respect to the historical average. Over the past ten years (40 quarters), XFOR's Enterprise Value was at its highest in in the March 2024 quarter at 279.77M. The Enterprise Value was at its lowest in in the September 2018 quarter at -7829074.20.

X4 Pharmaceuticals, Inc. (XFOR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of X4 Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

X4 Pharmaceuticals, Inc. (XFOR) Average Enterprise Value

How has XFOR Enterprise Value performed in the past?

The current Enterprise Value of X4 Pharmaceuticals, Inc. (XFOR) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

X4 Pharmaceuticals, Inc. (XFOR) Enterprise Value vs. Peers

How is XFOR’s Enterprise Value compared to its peers?

X4 Pharmaceuticals, Inc.’s Enterprise Value is less than Terns Pharmaceuticals, Inc. (458.36M), less than Day One Biopharmaceuticals, Inc. (1.01B), less than PDS Biotechnology Corporation (74.53M), less than Inozyme Pharma, Inc. (343.89M), less than Acumen Pharmaceuticals, Inc. (93.64M), less than Mereo BioPharma Group plc (582.99M), greater than eFFECTOR Therapeutics, Inc. (3.83M), greater than Elevation Oncology, Inc. (8.41M), greater than Hepion Pharmaceuticals, Inc. (2.24M), less than HOOKIPA Pharma Inc. (87.25M),

Build a custom stock screener for X4 Pharmaceuticals, Inc. (XFOR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like X4 Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

X4 Pharmaceuticals, Inc. (XFOR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like X4 Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.